• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Merck KGaA's CDMO unit continues to slide but company sees an uptick coming

cafead

Administrator
Staff member
  • cafead   May 15, 2024 at 11:02: PM
via Two years ago, when Merck KGaA restructured, forming a new life science business, the goal was to maximize the enticing potential of its contract development and manufacturing organization (CDMO). But achieving success in the post-COVID era has been a challenge for the CDMO industry.

article source